Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Malvern Instruments is Premier Sponsor of Inaugural PEGS China

Published: Tuesday, March 25, 2014
Last Updated: Monday, March 24, 2014
Bookmark and Share
Company will present its analytical toolkit for biopharma applications.

Malvern Instruments is premier sponsor of the inaugural PEGS China meeting. The PEGS China Protein & Antibody Engineering and Development summit is presented by Cambridge Healthtech Institute and takes place in Shanghai from 1 - 3 April 2014.

Malvern is participating in both the conference and the associated exhibition, with Dr Wei Qi, Senior Scientist within Malvern’s Bioscience Development Initiative, presenting a paper on ‘Emerging techniques for therapeutic protein characterization - viscosity, stability and sub-visible particles’.

Dr Wei Qi’s presentation is on 1 April, contributing to the ‘Analytical characterization and stability’ conference track, and will explore novel techniques for protein therapeutics characterization. He will describe how, using less than 10 mL sample, it is possible to measure viscosity up to 160 cP contemporaneously with concentration up to 200 mg/mL.

He will also talk about the novel combination of Raman Spectroscopy and Dynamic Light Scattering (DLS) for the simultaneous characterization of protein secondary and tertiary structure, and hydrodynamic size at high concentration. This new technology enables the assessment of conformational and colloidal stabilty under applied stresses, which is extremely useful when comparing different candidate bioformulations.

As part of the associated exhibition, Malvern will present instruments from the company’s rapidly advancing analytical toolkit for biopharmaceutical development. Established solutions, such as Viscotek size exclusion chromatography systems for assessing product purity and the Zetasizer range for sizing and zeta potential analysis for product stability, sit alongside exciting new technologies.

The Viscosizer 200, for example, which is used to assess bioformulation suitability and stability as early as late stage discovery, Archimedes, which uses the technique of resonant mass measurement for counting and measuring sub-micron and sub-visible aggregates and differentiating them from contaminants such as silicone oil in pharmaceutical formulations, and the Nanosight range of Nanoparticle Tracking Analysis instruments to quantify early protein aggregation.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Malvern takes ACHEMA Visitors from R&D Through to Product QC
Visitors to the Malvern Instruments stand at ACHEMA 2012 will see how the company’s range of complementary materials characterization technologies and instrumentation support the needs of manufacturing industry.
Wednesday, March 28, 2012
Malvern Scientists will lead Protein Characterization Workshop at PEGS Summit
Drs Kevin Mattison, Ulf Nobbmann and Jason Sanchez will lead a workshop at the 7th Annual PEGS.
Tuesday, September 13, 2011
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Overlooked Molecules Could Revolutionise our Understanding of the Immune System
Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
The Power Of Orthogonality In Assessing The Stability Of Biopharmaceuticals
By utilizing orthogonal techniques, researchers can maximize the secure application of all analytical results generated.
Dysfunction in Neuronal Transport Mechanism Linked to Alzheimer’s
Findings confirm mutation-caused problem but also reveal a new therapeutic target.
New Antibody Therapy Permanently Blocks SIV Infection
An international research team has developed an effective treatment strategy against the HIV-like Simian Immunodeficiency Virus (SIV) in rhesus macaques.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
DNA Vaccines Protect Monkeys Against Zika Virus
Two experimental Zika virus DNA vaccines developed by NIH scientists protected monkeys against Zika infection.
Rare Flu-Thwarting Mutation Discovered
Study finds protein mutation, that is encoded by influenza, causes the virus to lose any defence against the immune system.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos